Yellow Opacity in the Eye (Jaundice‑related Scleral Yellowing)
Overview
Scleral yellowing, often described as a “yellow opacity” in the whites of the eyes, is a visible sign of elevated bilirubin in the bloodstream (hyperbilirubinemia). While the term “jaundice” traditionally refers to the overall yellow discoloration of skin and mucous membranes, the eyes are usually the first place clinicians notice the change because the sclera (the tough outer layer of the eyeball) is thin and highly vascular.
Who it affects: Anyone with a condition that raises bilirubin can develop scleral yellowing. It is most common in:
- Adults with liver disease (hepatitis, cirrhosis, alcoholic liver disease).
- Newborns—about 60 % of term infants develop transient jaundice in the first week of life.
- Patients with hemolytic disorders (sickle cell disease, hereditary spherocytosis).
- Individuals taking medications that impair bilirubin processing (e.g., certain antibiotics, antiretrovirals).
Prevalence: In the United States, chronic liver disease affects roughly 4.5 % of adults, and up to 30 % of those will exhibit scleral yellowing at some point [1]. Neonatal jaundice occurs in 85 % of newborns worldwide, but clinically significant scleral yellowing (bilirubin > 12 mg/dL) is seen in 7‑10 % of term infants [2].
Symptoms
Scleral yellowing is often accompanied by a constellation of systemic and ocular signs. The degree of yellowing usually correlates with the bilirubin level.
Ocular signs
- Scleral yellowing: A uniform, pale‑to‑deep yellow tone of the whites of both eyes.
- Conjunctival yellowing: Occasionally the inner lining of the eyelids may appear yellow.
- Dryness or irritation: Bilirubin can affect tear production, leading to mild discomfort.
Systemic signs
- Yellowing of the skin, especially on the face, palms, and under the nails.
- Dark urine (urine that looks tea‑colored).
- Pale‑stool color (due to reduced bile pigment).
- Pruritus (itching), particularly on the palms and soles.
- Fatigue, abdominal discomfort, or right‑upper‑quadrant pain (liver‑related).
- Fever and chills (if infection is present).
- In newborns: poor feeding, lethargy, high‑pitch cry, or seizures (signs of severe hyperbilirubinemia).
Causes and Risk Factors
Yellow scleral discoloration is not a disease itself but a symptom of excess bilirubin. The underlying mechanisms fall into three broad categories:
Pre‑hepatic (hemolytic) causes
- Hereditary spherocytosis, G6PD deficiency, sickle cell disease.
- Autoimmune hemolytic anemia.
- Massive blood transfusions or severe burns.
Hepatic (liver) causes
- Viral hepatitis (A, B, C).
- Alcoholic liver disease and non‑alcoholic fatty liver disease (NAFLD).
- Cirrhosis from any etiology.
- Drug‑induced liver injury (e.g., acetaminophen overdose, isoniazid).
- Genetic disorders such as Gilbert’s syndrome (mild, often asymptomatic) and Crigler‑Najjar syndrome (severe).
Post‑hepatic (obstructive) causes
- Gallstones, biliary strictures, or tumors blocking bile flow.
- Pancreatic cancer at the head of the pancreas.
- Primary sclerosing cholangitis.
Risk factors
- Chronic alcohol consumption (>30 g/day for men, >20 g/day for women).
- Obesity and metabolic syndrome (predisposes to NAFLD).
- Unsafe injections or unprotected sex (risk for viral hepatitis).
- Family history of hereditary hemolytic or bilirubin‑processing disorders.
- Premature birth (<37 weeks) – higher risk of severe neonatal jaundice.
Diagnosis
Diagnosis begins with a visual inspection of the sclera, followed by a targeted work‑up to identify the bilirubin source.
Clinical examination
- Inspection under natural light; grading of scleral yellowing (0–4, with 4 = deep yellow).
- Assessment for additional signs (skin jaundice, abdominal tenderness, hepatomegaly).
Laboratory tests
- Serum total and direct bilirubin: Levels >2.5 mg/dL in adults generally produce visible scleral yellowing [3].
- Complete blood count (CBC) with reticulocyte count – evaluates hemolysis.
- Liver function panel (AST, ALT, ALP, GGT, albumin, PT/INR).
- Hepatitis serologies (HBsAg, anti‑HBc, anti‑HCV).
- Iron studies, ceruloplasmin (if Wilson disease suspected).
- Coombs test for autoimmune hemolysis.
Imaging
- Abdominal ultrasound – first‑line to detect biliary obstruction, gallstones, or liver morphology.
- MRCP or CT cholangiography – when ultrasound is inconclusive.
- FibroScan® for non‑invasive assessment of liver fibrosis.
Special tests for newborns
- Transcutaneous bilirubinometry (TcB) for rapid bedside screening.
- Serum bilirubin measurement (total & direct) if TcB > 12 mg/dL or rapid rise.
- Blood type & Coombs test to identify hemolytic disease of the newborn.
Treatment Options
Treatment is directed at lowering bilirubin and addressing the underlying cause.
Medication‑based therapies
- Ursodeoxycholic acid (UDCA): Improves bile flow in cholestatic disease.
- Corticosteroids: Used in autoimmune hepatitis.
- Antiviral agents: Direct‑acting antivirals for chronic hepatitis C, nucleos(t)ide analogues for hepatitis B.
- Phenobarbital: Sometimes used in newborns to induce bilirubin‑conjugating enzymes (controversial, less common now).
Procedural interventions
- Phototherapy: Blue‑light exposure converts bilirubin to water‑soluble isomers; first‑line for neonatal bilirubin >12 mg/dL or adult levels >20 mg/dL with rapid rise.
- Exchange transfusion: Reserved for life‑threatening hyperbilirubinemia (e.g., newborn bilirubin >30 mg/dL).
- Endoscopic retrograde cholangiopancreatography (ERCP): Removes biliary stones or places stents for obstruction.
- Liver transplantation: Considered in end‑stage liver disease with refractory jaundice.
Lifestyle and supportive measures
- Abstinence from alcohol; limit intake to ≤1 drink/day for women, ≤2 drinks/day for men.
- Weight loss (5‑10 % of body weight) improves NAFLD and bilirubin clearance.
- Hydration – adequate fluid intake supports renal excretion of conjugated bilirubin.
- Balanced diet rich in fruits, vegetables, and lean protein; avoid high‑fat meals that can exacerbate cholestasis.
Living with Yellow Opacity in the Eye (Jaundice‑related Scleral Yellowing)
While treatment addresses the medical root, daily coping strategies can reduce discomfort and improve quality of life.
- Skin care: Use mild, fragrance‑free soaps; moisturize daily to alleviate itching.
- Eye comfort: Artificial tears (preservative‑free) relieve dryness; avoid smoke and strong chemicals.
- Monitor bilirubin trends: Keep a log of symptoms, medication changes, and any new yellowing; share with your provider.
- Vaccinations: Hepatitis A and B vaccines protect against further liver injury.
- Regular follow‑up: At least every 3–6 months for chronic liver disease, more frequently if bilirubin is rising.
- Support groups: Organizations such as the American Liver Foundation provide education and community.
Prevention
Because scleral yellowing signals an underlying systemic issue, primary prevention targets the root causes.
- Vaccinate: Hepatitis A & B.
- Safe practices: Use condoms, avoid sharing needles, and limit alcohol.
- Healthy weight: Maintain BMI < 25 kg/m² to lower NAFLD risk.
- Medication safety: Discuss all over‑the‑counter and herbal supplements with a clinician to avoid hepatotoxic agents.
- Newborn care: Early feeding (breast or formula) reduces bilirubin buildup; ensure newborns are screened for jaundice before discharge.
Complications
If the underlying hyperbilirubinemia is not controlled, several serious complications may develop.
- Kernicterus: Deposition of bilirubin in the basal ganglia, leading to irreversible neurologic damage—most common in neonates with bilirubin >20 mg/dL.
- Chronic liver failure: Progressive fibrosis and cirrhosis can culminate in portal hypertension, ascites, and hepatic encephalopathy.
- Pruritus‑related sleep disturbance: Chronic itching may impair sleep and quality of life.
- Vitamin‑K deficiency: Severe cholestasis reduces fat‑soluble vitamin absorption, increasing bleeding risk.
- Psychosocial impact: Visible yellowing can cause embarrassment, anxiety, and depression.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you notice any of the following:
- Sudden, severe yellowing of the eyes or skin accompanied by confusion, lethargy, or seizures.
- Jaundice with high fever, abdominal pain, and vomiting—possible acute liver failure or cholangitis.
- Newborn with yellowing that spreads rapidly, a high‑pitched cry, poor feeding, or excessive sleepiness.
- Dark urine and pale stools together with intense itching and swelling of the abdomen (possible bile duct obstruction).
- Any sign of bleeding (easy bruising, blood in stool or urine) while bilirubin is markedly elevated.
Sources:
- Mayo Clinic. “Jaundice.” Updated 2023. https://www.mayoclinic.org
- American Academy of Pediatrics. “Management of Hyperbilirubinemia in the Newborn.” 2022. https://www.aap.org
- Cleveland Clinic. “Bilirubin Levels and Jaundice.” 2024. https://my.clevelandclinic.org
- World Health Organization. “Global Hepatitis Report 2023.” https://www.who.int
- National Institutes of Health. “Ursodeoxycholic Acid.” 2023. https://pubmed.ncbi.nlm.nih.gov